Stangl D, Born W, Fischer J A
Research Laboratory for Calcium Metabolism, Department of Orthopedic Surgery, University of Zurich, Switzerland.
Biochemistry. 1991 Sep 3;30(35):8605-11. doi: 10.1021/bi00099a016.
Calcitonin gene-related peptide (CGRP) receptors were solubilized from human (h) cerebellum with use of the zwitterionic detergent 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonic acid (CHAPS). Scatchard analysis of equilibrium binding data indicated that the soluble extract contained a single class of CGRP binding sites with apparent dissociation constants of 50 pM for the intact 125I-hCGRP-I(1-37) and 160 pM for the antagonist 125I-hCGRP-I(8-37). Unlabeled hCGRP-I and -II and hCGRP-I(8-37) displaced 125I-hCGRP-I from solubilized CGRP receptors with similar potencies (ID50 = 70-150 pM). Human CGRP-I(15-37), -(21-37), and -(28-37) were less potent (ID50 greater than or equal to 70 nM), suggesting that amino acid residues 8-14 may be important for maintaining high binding affinity. A novel photoreactive analogue of hCGRP-I, 125I-[C gamma-(4-azidoanilino)Asp3] hCGRP-I, was prepared by carbodiimide coupling of 4-azidoaniline to 125I-hCGRP-I. Photoaffinity labeling of soluble CGRP receptors with the photoreactive analogue and analysis by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and autoradiography revealed three specifically labeled binding proteins with apparent molecular weights (Mr) of 60,000, 54,000, and 17,000. Cross-linking of 125I-hCGRP-I and -II and 125I-hCGRP-I(8-37) to soluble CGRP binding sites using disuccinimidyl suberate revealed three specifically labeled binding proteins with the same Mr. The C-terminal fragment 125I-hCGRP-I(8-37), unlike the intact peptide, was, furthermore, cross-linked specifically to a 95,000 Mr protein. The CGRP receptor is N-glycosylated. Treatment with endoglycosidase F/N-glycosidase F converted the 60,000 and 54,000 to 46,000 and 41,000 Mr components.(ABSTRACT TRUNCATED AT 250 WORDS)
使用两性离子去污剂3-[(3-胆酰胺丙基)二甲基铵]-1-丙烷磺酸(CHAPS)从人小脑溶解降钙素基因相关肽(CGRP)受体。对平衡结合数据进行Scatchard分析表明,可溶性提取物含有一类CGRP结合位点,完整的125I-hCGRP-I(1-37)的表观解离常数为50 pM,拮抗剂125I-hCGRP-I(8-37)的表观解离常数为160 pM。未标记的hCGRP-I和-II以及hCGRP-I(8-37)以相似的效力(ID50 = 70 - 150 pM)从溶解的CGRP受体上取代125I-hCGRP-I。人CGRP-I(15-37)、-(21-37)和-(28-37)的效力较低(ID50大于或等于70 nM),表明氨基酸残基8 - 14对于维持高结合亲和力可能很重要。通过将4-叠氮基苯胺与125I-hCGRP-I进行碳二亚胺偶联,制备了一种新型的hCGRP-I光反应性类似物125I-[Cγ-(4-叠氮基苯胺)Asp3]hCGRP-I。用光反应性类似物对可溶性CGRP受体进行光亲和标记,并通过十二烷基硫酸钠-聚丙烯酰胺凝胶电泳和放射自显影分析,发现了三种特异性标记的结合蛋白,其表观分子量(Mr)分别为60,000、54,000和17,000。使用辛二酸二琥珀酰亚胺酯将125I-hCGRP-I和-II以及125I-hCGRP-I(8-37)与可溶性CGRP结合位点交联,发现了三种具有相同Mr的特异性标记的结合蛋白。此外,与完整肽不同,C末端片段125I-hCGRP-I(8-37)特异性交联到一种95,000 Mr的蛋白上。CGRP受体是N-糖基化的。用内切糖苷酶F/N-糖苷酶F处理后,60,000和54,000的成分转变为了46,000和41,000 Mr的成分。(摘要截短至250字)